Security record · archived quarter
PRGO
Perrigo Company plc · Healthcare · Drug Manufacturers - Specialty & Generic
15Tracked holders
n/aΔ holders
10.85MShares held
$278.70MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 100 | +3 | 113.08M | $1.17B | +10 | −8 |
| Q1 2026 | 101 | +4 | 101.94M | $1.09B | +11 | −8 |
| Q4 2025 | 98 | -2 | 106.62M | $1.48B | +3 | −4 |
| Q3 2025 | 19 | 0 | 63.63M | $1.42B | +1 | −2 |
| Q2 2025 | 17 | 0 | 58.29M | $1.56B | n/a | n/a |
| Q1 2025 | 14 | +1 | 29.73M | $833.59M | +1 | n/a |
| Q4 2024 | 13 | -2 | 24.99M | $642.39M | n/a | −2 |
| Q3 2024 | 14 | -1 | 13.07M | $342.69M | n/a | −1 |
| Q2 2024 | 15 | n/a | 10.85M | $278.70M | n/a | n/a |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 2.25M | n/a | $57.87M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Citadel Advisors ✦ | 2.22M | n/a | $56.96M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passive) | 1.37M | n/a | $35.11M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | AQR Capital Management ✦ | 970.64K | n/a | $24.93M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 5 | Wellington Management ✦ | 819.55K | n/a | $21.05M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 6 | GAMCO Investors ✦ | 797.09K | n/a | $20.47M | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 762.41K | n/a | $19.58M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Millennium Management ✦ | 451.92K | n/a | $11.61M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 436.65K | n/a | $11.21M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 273.20K | n/a | $7.02M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 249.42K | n/a | $6.41M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 108.37K | n/a | $2.78M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 13 | Gotham Asset Management ✦ | 91.47K | n/a | $2.35M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 39.17K | n/a | $1.01M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 14.20K | n/a | $364,656 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 326 holders, 151.12M shares, $1.41B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Sep 08
SC 13G/A: PRICE T ROWE ASSOCIATES INC /MD/
Aug 14
SC 13G/A: PRICE T ROWE ASSOCIATES INC /MD/
Jul 29
SC 13G/A: BlackRock, Inc.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API